Respiratory Medicine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Training Adaptations With and Without Ventilatory Training Device
Conditions: Healthy Interventions: Device: Respiratory Maximus Training Device; Device: No Respiratory Training Device Sponsors: University of South Carolina; MAXIMUS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Closed-loop syncHronization vErsuS convenTional Synchronization in sPontaneously Breathing Adult Nonivasive Patients
Conditions: Acute Respiratory Failure; Acute Respiratory Distress Syndrome; Chronic Respiratory Failure Interventions: Other: close-loop synchronization controller with SPONT mode; Other: Conventional Sponsors: Basaksehir Cam& Sakura Şehir Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

A Study for Assessing the Efficacy and Safety ParActin ® in Individuals With Upper Respiratory Tract Infections
Conditions: Upper Respiratory Tract Infections Interventions: Dietary Supplement: ParActin ®: 300 mg + MCC: 100 mg (± 10%) per Capsule; Dietary Supplement: MCC: 400 mg (± 10%) per Capsule Sponsors: Vedic Lifesciences Pvt. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

Covid-19 and Influenza Oral Vaccine Study
Conditions: covid19 Infection; Influenza, Human Interventions: Biological: Covid-19 vaccine; Biological: Influenza vaccine Sponsors: Vaxine Pty Ltd; Australian Respiratory and Sleep Medicine Institute Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

Risk Factors and Risk Grading Prediction of Perioperative Respiratory Adverse Events in Children
Conditions: Perioperative Respiratory Adverse Events Sponsors: Sichuan Provincial People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

The Effects of Positioning After Extubation of Preterm Infants on the Respiratory Functions
Conditions: Premature Infants Interventions: Other: The effect of positioning on respiratory functions of preterm infants after extubation. Sponsors: Karadeniz Technical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials

Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
Conditions: Viral Pneumonia Interventions: Other: other: Observational Sponsors: Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials

Investigating Long-term Health Effects and Complications in COVID-19 Recoveries
Conditions: COVID-19 Patients Interventions: Behavioral: respiratory rehabilitation Sponsors: Zhaohui Tong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials

A Clinical Pharmacological Study of Dose Halving of Dexamethasone in Pregnant Women With Preterm Labour With Preterm Birth at Greater Than or Equal to 34 Gestational Weeks (34GW+)
Conditions: Respiratory Distress Syndrome of Newborn Interventions: Drug: Dexamethasone Sponsors: Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials

Does the use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18 –24 months in very low birthweight infants?
DiscussionThe use of supplementary oxygen may be crucial but also potentially detrimental to preterm infants at birth. The HiLo trial is powered for the primary outcome and will address gaps in the evidence due to its pragmatic and inclusive design, targeting all extremely preterm infants. Should 60% initial oxygen concertation increase survival free of major neurodevelopmental outcomes at 18 –24 months corrected age, without severe adverse effects, this readily available intervention could be introduced immediately into clinical practice.Trial registrationThe trial was registered on January 31, 2019, at ClinicalTrials....
Source: Trials - April 4, 2024 Category: Research Source Type: clinical trials

A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy Adults
Conditions: Respiratory Syncytial Virus Infections Interventions: Biological: STR-V003/Placebo Sponsors: Starna Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials

Non-invasive Assessment of Inspiratory Effort and Tidal Distension During Non-invasive Ventilation (INSPIRE)
Conditions: Respiratory Disease; Artificial Respiration Interventions: Diagnostic Test: End-inspiratory Maneuvers Sponsors: University of Bari Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials

Evaluation of the Impact of Rehabilitation Strategies and Early Discharge After Respiratory Failure
Conditions: Acute Respiratory Failure Interventions: Behavioral: Standard of Care; Behavioral: Rehabilitation Sponsors: Hospital Israelita Albert Einstein Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

Physical Therapy Students: Well-being
Conditions: Anxiety State; Motivation; Life Stress; Sleep, Inadequate Interventions: Other: Respiratory breathing techniques group Sponsors: University of Medicine and Pharmacy " Victor Babes " Timisoara Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC)
Conditions: Non-small Cell Lung Cancer Interventions: Drug: cadonilimab Sponsors: Guangzhou Institute of Respiratory Disease Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials